Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

611 trials with published results (12%)

Research Maturity

2819 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.6%

402 terminated out of 5271 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

13%

665 trials in Phase 3/4

Results Transparency

22%

611 of 2819 completed with results

Key Signals

611 with results88% success402 terminated

Data Visualizations

Phase Distribution

3,127Total
Not Applicable (1130)
Early P 1 (30)
P 1 (446)
P 2 (856)
P 3 (483)
P 4 (182)

Trial Status

Completed2,819
Unknown1,418
Terminated402
Withdrawn276
Recruiting157
Active Not Recruiting132

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 2819 completed trials

Clinical Trials (5271)

Showing 20 of 20 trials
NCT04466683Phase 2Active Not RecruitingPrimary

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

NCT07149428Not Yet Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT05369611Enrolling By InvitationPrimary

COVID-19 Experiences in the SELF Cohort

NCT05855330Phase 2RecruitingPrimary

Arginine Replacement Therapy in COVID-19

NCT07095231Phase 1Active Not RecruitingPrimary

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

NCT07527130Not Yet RecruitingPrimary

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

NCT04411147Active Not RecruitingPrimary

A Longitudinal Study of COVID-19 Sequelae and Immunity

NCT07221162Phase 1RecruitingPrimary

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07300839Phase 3Active Not RecruitingPrimary

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT05543616Phase 3Active Not Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

NCT04896606Phase 1RecruitingPrimary

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

NCT07183709Phase 1Active Not RecruitingPrimary

Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

NCT02081326Phase 2Active Not Recruiting

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

NCT04717024TerminatedPrimary

The Nanowear Wearable Covid-19 Observational and Analysis Trend

NCT07516977Not ApplicableNot Yet Recruiting

Noseguard for Prevention of Respiratory Infections in Real-World Use

NCT04896060CompletedPrimary

The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

NCT04794829Recruiting

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

NCT05266222Recruiting

Respiratory Virus Sampling and Repository

NCT04367857RecruitingPrimary

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

NCT06452082Completed

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

Scroll to load more

Research Network

Activity Timeline